CryoCell Historical Financial Ratios
| CCEL Stock | USD 7.40 0.36 5.11% |
CryoCell International is presently reporting on over 119 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.2, Days Sales Outstanding of 79.26 or Free Cash Flow Yield of 0.0271 will help investors to properly organize and evaluate CryoCell International financial condition quickly.
CryoCell |
About CryoCell Financial Ratios Analysis
CryoCell InternationalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CryoCell International investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CryoCell financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CryoCell International history.
CryoCell International Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing CryoCell International stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CryoCell International sales, a figure that is much harder to manipulate than other CryoCell International multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is CryoCell International dividend as a percentage of CryoCell International stock price. CryoCell International dividend yield is a measure of CryoCell International stock productivity, which can be interpreted as interest rate earned on an CryoCell International investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Most ratios from CryoCell International's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CryoCell International current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.At this time, CryoCell International's Payout Ratio is quite stable compared to the past year. PFCF Ratio is expected to rise to 32.92 this year, although the value of PTB Ratio is projected to rise to (4.42).
| 2024 | 2025 (projected) | Dividend Yield | 0.19 | 0.2 | Price To Sales Ratio | 1.64 | 1.56 |
CryoCell International fundamentals Correlations
Click cells to compare fundamentals
CryoCell International Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CryoCell International fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 2.0 | 1.96 | 3.49 | 1.22 | 1.64 | 1.56 | |
| Ptb Ratio | (22.91) | 24.08 | (24.27) | (4.05) | (4.65) | (4.42) | |
| Days Sales Outstanding | 74.09 | 66.38 | 72.72 | 76.58 | 88.07 | 79.26 | |
| Book Value Per Share | (0.33) | 0.51 | (0.18) | (1.32) | (1.52) | (1.44) | |
| Operating Cash Flow Per Share | 0.75 | 1.04 | 0.97 | 1.01 | 1.07 | 0.96 | |
| Stock Based Compensation To Revenue | 0.02 | 0.0104 | 0.0152 | 0.0261 | 0.03 | 0.0279 | |
| Capex To Depreciation | 0.71 | 5.24 | 9.49 | 4.47 | 4.02 | 4.22 | |
| Pb Ratio | (22.91) | 24.08 | (24.27) | (4.05) | (4.65) | (4.42) | |
| Ev To Sales | 2.07 | 1.83 | 3.3 | 1.55 | 2.02 | 1.92 | |
| Roic | 0.17 | 0.0764 | 0.0698 | (0.21) | (0.19) | (0.18) | |
| Inventory Turnover | 10.41 | 9.76 | 10.33 | 10.98 | 12.63 | 11.73 | |
| Net Income Per Share | 0.27 | 0.45 | 0.26 | (1.14) | (1.03) | (0.98) | |
| Days Of Inventory On Hand | 35.05 | 37.4 | 35.34 | 33.24 | 38.23 | 36.32 | |
| Payables Turnover | 10.09 | 6.03 | 5.48 | 2.66 | 3.06 | 2.91 | |
| Research And Ddevelopement To Revenue | 7.66E-4 | 0.001727 | 0.0127 | 0.0374 | 0.043 | 0.0408 | |
| Capex To Revenue | 0.0208 | 0.0144 | 0.24 | 0.57 | 0.28 | 0.17 | |
| Cash Per Share | 1.28 | 1.02 | 0.2 | 0.12 | 0.11 | 0.1 | |
| Pocfratio | 7.21 | 12.71 | 4.32 | 5.0 | 4.5 | 4.28 | |
| Interest Coverage | 4.96 | 2.9 | 2.64 | (9.95) | (8.95) | (9.4) | |
| Capex To Operating Cash Flow | 0.0531 | 0.88 | 2.0 | 0.86 | 0.98 | 0.58 | |
| Pfcf Ratio | 7.62 | 103.33 | (4.3) | 34.84 | 31.36 | 32.92 | |
| Days Payables Outstanding | 36.18 | 60.49 | 66.64 | 137.25 | 157.84 | 98.15 | |
| Income Quality | 2.34 | 3.8 | 3.09 | (0.94) | (0.84) | (0.8) | |
| Roe | (1.36) | 0.5 | (1.82) | 0.86 | 0.99 | 1.04 | |
| Ev To Operating Cash Flow | 6.72 | 12.02 | 5.47 | 6.18 | 7.11 | 6.75 | |
| Pe Ratio | 16.84 | 48.35 | 13.35 | (4.69) | (4.22) | (4.01) | |
| Return On Tangible Assets | 0.0848 | 0.049 | 0.058 | (0.16) | (0.15) | (0.14) | |
| Ev To Free Cash Flow | 7.1 | 97.75 | (5.46) | 43.03 | 38.73 | 40.66 | |
| Earnings Yield | 0.0594 | 0.0207 | 0.0749 | (0.21) | (0.19) | (0.18) | |
| Intangibles To Total Assets | 0.0752 | 0.3 | 0.26 | 0.0479 | 0.0431 | 0.0326 | |
| Net Debt To E B I T D A | (0.57) | (1.02) | 1.49 | (1.01) | (1.16) | (1.1) | |
| Current Ratio | 1.0 | 1.13 | 0.75 | 0.49 | 0.45 | 0.52 | |
| Tangible Book Value Per Share | (0.75) | (1.72) | (2.2) | (1.67) | (1.92) | (1.83) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Earnings Share (1.07) | Revenue Per Share | Quarterly Revenue Growth 0.025 | Return On Assets |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.